As of Wednesday, February 18, Rapid Micro Biosystems, Inc.’s RPID share price has surged by 6.09%, which has investors questioning if this is right time to sell.
Roozbeh Ghaffari, who goes by “Rooz” to the people who know him, is co-founder and chief executive of Epicore Biosystems. In a recent interview with me conducted over email, he described his company ...
The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of the Company, or following a bona fide period of non-employment, as an ...
Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is redefining histology workflows ...
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, ...
Trenchant BioSystems has signed a nonbinding letter of intent with Invetech to form a strategic alliance aimed at advancing Trenchant’s AutoCell system.
Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect BiosystemsAspect will lead development, manufacturing and commercialisation, and Novo Nordisk will ...
As of Thursday, February 12, Rapid Micro Biosystems, Inc.’s RPID share price has dipped by 5.71%, which has investors ...
WATERTOWN, MA & HARLEYSVILLE, PA — Hyperion Biosystems and Colorcon have announced a licensing agreement aimed at revolutionizing the fight against counterfeit pharmaceutical and nutraceutical ...
Hosted on MSN
Imagion Biosystems issues new shares on vesting of performance rights, reaffirms imminent HER2+ FDA filing
Imagion Biosystems Ltd. ( (AU:IBX)) just unveiled an announcement. Imagion Biosystems has issued 1.4 million fully paid ordinary shares at a deemed price of 2.2 cents each following the vesting of ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Jun 5, 2014 at 12:00 ...
Novo Nordisk and Aspect Biosystems have started a new phase in their ongoing partnership focused on curative cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results